The FDA approved Qdolo (tramadol hydrochloride), developed by Athena Bioscience, LLC on September 1, 2020, for the management of pain.Qdolo, an opioid agonist, is approved for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.According to CDC, 50 million adults in the U.S. experience chronic daily pain with 19.5 million adults face chronic pain that interferes with their daily activities.The drug comes with a boxed warning about the risks of addiction, abuse, and misuse, which can lead to overdose and death.